Guntur: Nagpur Kalyani receives approval for establishment of AIIMS

Published On 2016-03-16 07:55 GMT   |   Update On 2016-03-16 07:55 GMT

New Delhi:Three new AIIMS to come up at  Mangalagiri near Guntur in Andhra Pradesh, Nagpur in Maharashtra & Kalyani in West Bengal at the cost of Rs. 1618 crore,Rs 1577 crore & Rs. 1754 respectively. The projects have received the centres approval under the  Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) involving a total financial implication of Rs. 4949 crore. An announcement...

Login or Register to read the full article
New Delhi:Three new AIIMS to come up at  Mangalagiri near Guntur in Andhra Pradesh, Nagpur in Maharashtra & Kalyani in West Bengal at the cost of Rs. 1618 crore,Rs 1577 crore & Rs. 1754 respectively. The projects have received the centres approval under the  Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) involving a total financial implication of Rs. 4949 crore. An announcement to this effect was made by Mr. JP Nadda, Health Minister in the Rajya Sabha today.

The projects are supposed to reach completion within a period of 60 months from the date of commencement, comprising of a 12 month pre- construction phase, a construction period of 42 months and a stabilization phase of 60 months.

According to Nadda each institution will have an intake of 100 under-graduate students and will impart PG/Doctoral courses in various disciplines. The projects also have provisions for Nursing Colleges with programmes in B.Sc (Nursing) and M.Sc (Nursing) students.The  total bed strength coming  to 960 beds, with 42 speciality/super-speciality departments.

The three AIIMS establishments  would also consists of speciality, super speciality, basic science and other departments.

 

 

 

 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News